Blydt-Hansen, Ingrid, Michelle Bech, and Shannon Jackson. “Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program”. Journal of Hematology 14, no. 5 (January 1, 2025): 257–261. Accessed December 25, 2025. https://jh.elmerpub.com/jh/article/view/2113.